Does the use of chitosan contribute to oxalate kidney stone formation?

Marine Drugs

Volumn 13, Issue 1, 2015, Pages 141-158

  Queiroz, Moacir Fernandes ^a   Melo, Karoline Rachel Teodosio ^a   Sabry, Diego Araujo ^b,c   Sassaki, Guilherme Lanzi ^b   Rocha, Hugo Alexandre Oliveira ^a  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO NORTE   (Brazil)

^b FEDERAL UNIVERSITY OF PARANÁ   (Brazil)

^c FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Antioxidant activity; Calcium oxalate monohydrate crystals; Copper chelation; Urolithiasis

Indexed keywords

CALCIUM OXALATE; CATALASE; CHITOSAN; GLUCOSE 6 PHOSPHATE DEHYDROGENASE; GLUTATHIONE PEROXIDASE; GLUTATHIONE TRANSFERASE; GLYCOSAMINOGLYCAN; NANOPARTICLE; SUPEROXIDE DISMUTASE; ANTIOXIDANT;

ANTIOXIDANT ACTIVITY; ARTICLE; CHELATION; CONFORMATION; CRYSTALLIZATION; DEACETYLATION; HUMAN; IMAGE ANALYSIS; IN VITRO STUDY; IN VIVO STUDY; INFRARED SPECTROSCOPY; LIPID PEROXIDATION; MORPHOLOGY; NEPHROLITHIASIS; NUCLEAR MAGNETIC RESONANCE; OXIDATIVE STRESS; PROTEIN BLOOD LEVEL; UROLITHIASIS; ZETA POTENTIAL; DRUG EFFECTS; KIDNEY; KIDNEY CALCULI; METABOLISM; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY;

ANTIOXIDANTS; CALCIUM OXALATE; CHITOSAN; CRYSTALLIZATION; HUMANS; KIDNEY; KIDNEY CALCULI; MAGNETIC RESONANCE SPECTROSCOPY; SPECTROSCOPY, FOURIER TRANSFORM INFRARED;

EID: 84921654533     PISSN: None     EISSN: 16603397     Source Type: Journal    
DOI: 10.3390/md13010141     Document Type: Article

References (48)

1. Hayes, M. Chitin, Chitosan and their Derivatives from Marine Rest Raw Materials: Potential Food and Pharmaceutical Applications. In Marine Bioactive Compounds; Springer: New York, NY, USA, 2012; pp. 115-128.
2. Jayakumara, R.; Menon, D.; Manzoor, K.; Nair, S.V.; Tamura, H. Biomedical applications of chitin and chitosan based nanomaterials-A short review. Carbohydr. Polym. 2010, 82, 227-232.
3. Laurienzo, P. Marine Polysaccharides in Pharmaceutical Applications: An Overview. Mar. Drugs 2010, 8, 2435-2465.
4. Casettari, L.; Vllasaliu, D.; Lam, J.K.; Soliman, M.; Illum, L. Biomedical applications of amino acid-modified chitosans: A review. Biomaterials 2012, 33, 7565-7583.
5. st ed.; Nova Science: New York, NY, USA, 2013; pp. 454-463.
6. Kean, T.; Thanou, M. Biodegradation, biodistribution and toxicity of chitosan. Adv. Drug. Deliv. Rev. 2010, 62, 3-11.
7. Baldrick, P. The safety of chitosan as a pharmaceutical excipient. Regul. Toxicol. Pharmacol. 2010, 56, 290-299.
8. Garcia-Fuentes, M.; Alonso, M.J. Chitosan-based drug nanocarriers: Where do we stand? J. Control. Release 2012, 161, 496-504.
9. Wang, J.J.; Zeng, Z.W.; Xiao, R.Z.; Xie, T.; Zhou, G.L.; Zhan, X.R.; Wang, S.L. Recent advances of chitosan nanoparticles as drug carriers. Int. J. Nanomed. 2011, 6, 765-774.
10. Zhang, H.L.; Tao, Y.; Guo, J.; Hu, Y.M.; Su, Z.Q. Hypolipidemic effects of chitosan nanoparticles in hyperlipidemia rats induced by high fat diet. Int. Immunopharmacol. 2011, 11, 457-461.
11. Xia, W.; Liu, P.; Zhang, J.; Chen, J. Biological activities of chitosan and chitooligosaccharides. Food Hydrocoll. 2011, 25, 170-179.
12. Yuan, Z.X.; Zhang, Z.R.; Zhu, D.; Sun, X.; Gong, T.; Liu, J.; Luan, C.T. Specific renal uptake of randomly 50% N-acetylated low molecular weight chitosan. Mol. Pharm. 2009, 6, 305-314.
13. Wada, M.; Nishimura, Y.; Watanabe, Y.; Takita, T.; Innami, S. Accelerating effect of chitosan Intake on Urinary calcium excretion by rats. Biosci. Biotech. Biochem. 1997, 61, 1206-1208.
14. Mahmood, A.; Silbergleit, A.; Olson, R.; Cotant, M. Urolithiasis: The influence of stone size on management. Nat. Clin. Pract. Urol. 2007, 4, 570-573.
15. Finlayson, B. Phisicochemical aspects of urolithiasis. Kidney Int. 1978, 13, 344-360.
16. Ogawa, Y.; Miyazato, T.; Hatano, T. Oxalate and Urinary Stones. World J. Surg . 2000, 24, 1154-1159.
17. Thamilselvan, S.; Hackett, R.L.; Khan, S.R. Lipid peroxidation in ethylene glycol induced hyperoxaluria and calcium oxalate nephrolithiasis. J. Urol. 1997, 157, 1059-1063.
18. Selvam, R. Calcium oxalate stone disease: Role of lipid peroxidation and antioxidants. Urol. Res. 2002, 30, 35-47.
19. Anbazhagan, M.; Hariprasad, C.; Samudram, P.; Latha, P.; Latha, M.; Selvam, R. Effect of oral supplementation of vitamin E in hyperoxaluric patients on urinary risk factors. J. Clin. Biochem. Nutr. 1999, 27, 37-47.
20. Davalos, M.; Konno, S.; Eshghi, M.; Choudhury, M. Oxidative renal cell injury induced by calcium oxalate crystal and renoprotection with antioxidants: A possible role of oxidative stress in nephrolithiasis. J. Endourol. 2010, 24, 339-345.
21. Holoch, P.A.; Tracy, C.R. Antioxidants and self-reported history of kidney stones: The National Health and Nutrition Examination Survey. J. Endourol. 2011, 25, 1903-1908.
22. Melo-Silveira, R.F.; Fidelis, G.P.; Costa, M.S.S.P.; Telles, C.B.S.; Dantas-Santos, N.; Elias, S.O.; Ribeiro, V.B.; Barth, A.L.; Macedo, A.J.; Leite, E.L.; et al. In Vitro Antioxidant, Anticoagulant and Antimicrobial Activity and in Inhibition of Cancer Cell Proliferation by Xylan Extracted from Corn Cobs. Int. J. Mol. Sci. 2012, 13, 409-426.
23. Wolkers, W.F.; Oliver, A.E.; Tablina, F.; Crowea, J.H. A Fourier-transform infrared spectroscopy study of sugar glasses. Carbohydr. Res . 2004, 339, 1077-1085.
24. Silva, F.R.F.; Dore, C.M.P.G.; Marques, C.T.; Nascimento, M.S.; Benevides, N.M.B.; Rocha, H.A.O.; Chavante, S.F.; Leite, E.L. Anticoagulant activity, paw edema and pleurisy induced carrageenan: Action of major types of commercial carrageenans. Carbohydr. Polym. 2010, 79, 26-33.
25. Lim, S.H.; Hudson, S.M. Synthesis and antimicrobial activity of a water-soluble chitosan derivative with a fiber-reactive group. Carbohydr. Res. 2004, 339, 313-319.
26. Vino, A.B.; Ramasamy, P.; Shanmugam, V.; Shanmugam, A. Extraction, characterization and in vitro antioxidative potential of chitosan and sulfated chitosan from Cuttlebone of Sepia aculeata Orbigny, 1848. Asian. Pac. J. Trop. Biomed. 2012, 2, S334-S341.
27. Song, C.; Yu, H.; Zhang, M.; Yang, Y.; Zhang, G. Physicochemical properties and antioxidant activity of chitosan from the blowfly Chrysomya megacephala larvae. Int. J. Biol. Macromol. 2013, 60, 347-354.
28. Costa, M.S.S.P.; Costa, L.S.; Cordeiro, S.L.; Almeida-Lima, J.; Dantas-Santos, N.; Magalhães, K.D.; Sabry, D.A.; Albuquerque, I.R.L.; Pereira, M.R.; Leite, E.L.; et al. Evaluating the possible anticoagulant and antioxidant effects of sulfated polysaccharides from the tropical green alga Caulerpa cupressoides var. flabellate. J. Appl. Phycol . 2012, 24, 1159-1167.
29. Czechowska-Biskup, R.; Jarosińska, D.; Rokita, B.; Ulański, P.; Rosiak, J.M. Determination of Degree of Deacetylation of Chitosan-Comparision of Methods. Prog. Chem. Appl. Chitin Deriv. 2012, XVII, 5-20.
30. Lavertu, M.; Xia, Z.; Serreqi, A.; Berrada, M.; Rodrrigues, A.; Wang, D.; Buschmann, M.; Gupta, A. A validated H NMR method for the determination of the degree of deacetylation of chitosan. J. Pharm. Biomed. Anal. 2003, 32, 1149-1158.
31. Wickens, A.P. Ageing and the free radical theory. Respir. Physiol. 2001, 128, 379-391.
32. Cuzzocrea, S.; McDonald, M.C.; Mazzon, E.; Filipe, H.M.; Centorrino, T.; Lepore, V.; Terranova, M.L.; Ciccolo, A.; Caputi, A.P.; Thiemermann, C. Beneficial effects of tempol, a membrane-permeable radical scavenger, on the multiple organ failure induced by zymosan in the rat. Crit. Care Med. 2001, 29, 102-111.
33. Costa, L.S.; Fidelis, G.P.; Cordeiro, S.L.; Oliveira, R.M.; de Sabry, D.A.; Camara, R.B.G.; Nobre, L.T.D.B.; da Costa, M.S.S.P.; de Lima, J.A.; de Farias, E.H.C.; et al. Biological activities of sulfated polysaccharides from tropical seaweeds. Biomed. Pharmacother. 2010, 64, 21-28.
34. Prabu, K.; Natarajan, E. In Vitro Antimicrobial and Antioxidant Activity of Chitosan Isolated from Podophthalmus vigil. J. App. Pharm. Sci. 2012, 9, 075-082.
35. Kuppusamy, S.K.; Karuppaiah, J. In Vitro evaluation of free radical scavenging activity of chitosan. Int. J. Pharm. Life Sci. 2013, 4, 2685-2690.
36. Chien, P.-J.; Sheu, F.; Huang, W.-T.; Su, M.-S. Effect of molecular weight of chitosans on their antioxidative activities in apple juice. Food Chem. 2007, 155, 221-226.
37. Xing, R.; Liu, S.; Guo, Z.; Yu, H.; Wang, P.; Lia, L.Z.; Lia, P. Relevance of molecular weight of chitosan and its derivatives and their antioxidant activities in vitro. Bioorg. Med. Chem. 2005, 13, 1573-1577.
38. Melo, K.R.T.; Câmara, R.B.G.; Queiroz, M.F.; Vidal, A.A.J.; Lima, C.R.M.; Melo-Silveira, R.F.; Almeida-Lima, J.; Rocha, H.A.O. Evaluation of Sulfated Polysaccharides from the Brown Seaweed Dictyopteris Justii as Antioxidant Agents and as Inhibitors of the Formation of Calcium Oxalate Crystals. Molecules 2013, 18, 14543-14563.
39. Zhang, C.Y.; Wu, W.H.; Wang, J.; Lan, M.B. Antioxidant properties of polysaccharide from the brown seaweed Sargassum graminifolium (Turn.), and its effects on calcium oxalate crystallization. Mar. Drugs 2012, 10, 119-130.
40. Kulaksizoglu, S.; Sofikerim, M.; Cevik, C. In vitro effect of lemon and orange juices on calcium oxalate crystallization. Int. Urol. Nephrol. 2008, 40, 589-594.
41. Green, W.; Ratan, H. Molecular mechanisms of urolithiasis. Urology 2013, 81, 701-704.
42. Lieske, J.C.; Deganello, S.; Toback, F.G. Cell-crystal interactions and kidney stone formation. Nephron 1999, 81, 8-17.
43. Yuen, J.W.; Gohel, M.D.; Poon, N.W.; Shum, D.K.; Tam, P.C.; Au, D.W. The initial and subsequent inflammatory events during calcium oxalate lithiasis. Clin. Chim. Acta 2010, 411, 1018-1026.
44. Baneld, J.F.; Welch, S.A.; Zhang, H.; Ebert, T.T.; Penn, R.L. Aggregation-Based Crystal Growth and Microstructure Development in Natural Iron Oxyhydroxide Biomineralization Products. Science 2000, 289, 751-754.
45. Escobar, C.; Neira-Carrillo, A.; Fernández, M.S.; Arias, J.L. Biomineralization: From Paleontology to Materials Science; Arias, J.L., Fernández, M.S., Eds.; Editorial Universitaria: Santiago, Chile, 2007; pp. 343-358.
46. Gades, M.D.; Stern, J.S. Chitosan supplementation and fat absorption in men and women. J. Am. Diet. Assoc. 2005, 105, 72-77.
47. Giri, T.K.; Thakur, A.; Alexander, A.; Ajazuddin; Badwaik, H.; Tripathi, D.K. Modified chitosan hydrogels as drug delivery and tissue engineering systems: Present status and applications. Acta Pharm. Sin. B 2012, 2, 439-449.
48. Anton, A. Colorimetric Estimation of Aluminum with Pyrocatechol Violet. Anal. Chem. 1960, 32, 725-726.